Global Paclitaxel Market Growth 2023-2029

Publisher Name :
Date: 04-Jan-2023
No. of pages: 101

Paclitaxel is a mitotic inhibitor used in Cancer chemotherapy; Paclitaxel was discovered in 1962 as a result of a U.S. National Cancer Institute-funded screening program; Monroe Wall and Mansukh Wani isolated the drug from the bark of the Pacific yew, Taxus brevifolia, and named it "taxol".

LPI (LP Information)' newest research report, the "Paclitaxel Industry Forecast" looks at past sales and reviews total world Paclitaxel sales in 2022, providing a comprehensive analysis by region and market sector of projected Paclitaxel sales for 2023 through 2029. With Paclitaxel sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Paclitaxel industry.

This Insight Report provides a comprehensive analysis of the global Paclitaxel landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Paclitaxel portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Paclitaxel market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Paclitaxel and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Paclitaxel.

The global Paclitaxel market size is projected to grow from US$ 115 million in 2022 to US$ 203.7 million in 2029; it is expected to grow at a CAGR of 203.7 from 2023 to 2029.

North America and China are the largest producer of Paclitaxel, with a market share about 35% separately. Phyton, ScinoPharm, Huiang biopharma, Southpharma and Novasep are the top 5 manufacturers of industry, and they had more than 60% combined market share.

This report presents a comprehensive overview, market shares, and growth opportunities of Paclitaxel market by product type, application, key manufacturers and key regions and countries.

Market Segmentation:

Segmentation by type

- Natural Paclitaxel API

- Semi-synthetic Paclitaxel API

Segmentation by application

- Ovarian Cancer

- Cervical Cancer

- Breast Cancer

- Others

The below companies that are profiled

- Americas

- - United States

- - Canada

- - Mexico

- - Brazil

- APAC

- - China

- - Japan

- - Korea

- - Southeast Asia

- - India

- - Australia

- Europe

- - Germany

- - France

- - UK

- - Italy

- - Russia

- Middle East & Africa

- - Egypt

- - South Africa

- - Israel

- - Turkey

- - GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

- Phyton

- ScinoPharm

- Novasep

- Samyang

- Polymed

- TAPI (Teva)

- Fresenius-kabi

- Huiang biopharma

- Southpharma

- Yunnan Hande

- Hainan Yew Pharm

- Jiangsu Yew Biotechnology

Key Questions Addressed in this Report

What is the 10-year outlook for the global Paclitaxel market?

What factors are driving Paclitaxel market growth, globally and by region?

Which technologies are poised for the fastest growth by market and region?

How do Paclitaxel market opportunities vary by end market size?

How does Paclitaxel break out type, application?

What are the influences of COVID-19 and Russia-Ukraine war?

Global Paclitaxel Market Growth 2023-2029

Table of Contents

1 Scope of the Report
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Paclitaxel Annual Sales 2018-2029
2.1.2 World Current & Future Analysis for Paclitaxel by Geographic Region, 2018, 2022 & 2029
2.1.3 World Current & Future Analysis for Paclitaxel by Country/Region, 2018, 2022 & 2029
2.2 Paclitaxel Segment by Type
2.2.1 Natural Paclitaxel API
2.2.2 Semi-synthetic Paclitaxel API
2.3 Paclitaxel Sales by Type
2.3.1 Global Paclitaxel Sales Market Share by Type (2018-2023)
2.3.2 Global Paclitaxel Revenue and Market Share by Type (2018-2023)
2.3.3 Global Paclitaxel Sale Price by Type (2018-2023)
2.4 Paclitaxel Segment by Application
2.4.1 Ovarian Cancer
2.4.2 Cervical Cancer
2.4.3 Breast Cancer
2.4.4 Others
2.5 Paclitaxel Sales by Application
2.5.1 Global Paclitaxel Sale Market Share by Application (2018-2023)
2.5.2 Global Paclitaxel Revenue and Market Share by Application (2018-2023)
2.5.3 Global Paclitaxel Sale Price by Application (2018-2023)
3 Global Paclitaxel by Company
3.1 Global Paclitaxel Breakdown Data by Company
3.1.1 Global Paclitaxel Annual Sales by Company (2018-2023)
3.1.2 Global Paclitaxel Sales Market Share by Company (2018-2023)
3.2 Global Paclitaxel Annual Revenue by Company (2018-2023)
3.2.1 Global Paclitaxel Revenue by Company (2018-2023)
3.2.2 Global Paclitaxel Revenue Market Share by Company (2018-2023)
3.3 Global Paclitaxel Sale Price by Company
3.4 Key Manufacturers Paclitaxel Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Paclitaxel Product Location Distribution
3.4.2 Players Paclitaxel Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Paclitaxel by Geographic Region
4.1 World Historic Paclitaxel Market Size by Geographic Region (2018-2023)
4.1.1 Global Paclitaxel Annual Sales by Geographic Region (2018-2023)
4.1.2 Global Paclitaxel Annual Revenue by Geographic Region (2018-2023)
4.2 World Historic Paclitaxel Market Size by Country/Region (2018-2023)
4.2.1 Global Paclitaxel Annual Sales by Country/Region (2018-2023)
4.2.2 Global Paclitaxel Annual Revenue by Country/Region (2018-2023)
4.3 Americas Paclitaxel Sales Growth
4.4 APAC Paclitaxel Sales Growth
4.5 Europe Paclitaxel Sales Growth
4.6 Middle East & Africa Paclitaxel Sales Growth
5 Americas
5.1 Americas Paclitaxel Sales by Country
5.1.1 Americas Paclitaxel Sales by Country (2018-2023)
5.1.2 Americas Paclitaxel Revenue by Country (2018-2023)
5.2 Americas Paclitaxel Sales by Type
5.3 Americas Paclitaxel Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Paclitaxel Sales by Region
6.1.1 APAC Paclitaxel Sales by Region (2018-2023)
6.1.2 APAC Paclitaxel Revenue by Region (2018-2023)
6.2 APAC Paclitaxel Sales by Type
6.3 APAC Paclitaxel Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Paclitaxel by Country
7.1.1 Europe Paclitaxel Sales by Country (2018-2023)
7.1.2 Europe Paclitaxel Revenue by Country (2018-2023)
7.2 Europe Paclitaxel Sales by Type
7.3 Europe Paclitaxel Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Paclitaxel by Country
8.1.1 Middle East & Africa Paclitaxel Sales by Country (2018-2023)
8.1.2 Middle East & Africa Paclitaxel Revenue by Country (2018-2023)
8.2 Middle East & Africa Paclitaxel Sales by Type
8.3 Middle East & Africa Paclitaxel Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Paclitaxel
10.3 Manufacturing Process Analysis of Paclitaxel
10.4 Industry Chain Structure of Paclitaxel
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Paclitaxel Distributors
11.3 Paclitaxel Customer
12 World Forecast Review for Paclitaxel by Geographic Region
12.1 Global Paclitaxel Market Size Forecast by Region
12.1.1 Global Paclitaxel Forecast by Region (2024-2029)
12.1.2 Global Paclitaxel Annual Revenue Forecast by Region (2024-2029)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Paclitaxel Forecast by Type
12.7 Global Paclitaxel Forecast by Application
13 Key Players Analysis
13.1 Phyton
13.1.1 Phyton Company Information
13.1.2 Phyton Paclitaxel Product Portfolios and Specifications
13.1.3 Phyton Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.1.4 Phyton Main Business Overview
13.1.5 Phyton Latest Developments
13.2 ScinoPharm
13.2.1 ScinoPharm Company Information
13.2.2 ScinoPharm Paclitaxel Product Portfolios and Specifications
13.2.3 ScinoPharm Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.2.4 ScinoPharm Main Business Overview
13.2.5 ScinoPharm Latest Developments
13.3 Novasep
13.3.1 Novasep Company Information
13.3.2 Novasep Paclitaxel Product Portfolios and Specifications
13.3.3 Novasep Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.3.4 Novasep Main Business Overview
13.3.5 Novasep Latest Developments
13.4 Samyang
13.4.1 Samyang Company Information
13.4.2 Samyang Paclitaxel Product Portfolios and Specifications
13.4.3 Samyang Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.4.4 Samyang Main Business Overview
13.4.5 Samyang Latest Developments
13.5 Polymed
13.5.1 Polymed Company Information
13.5.2 Polymed Paclitaxel Product Portfolios and Specifications
13.5.3 Polymed Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.5.4 Polymed Main Business Overview
13.5.5 Polymed Latest Developments
13.6 TAPI (Teva)
13.6.1 TAPI (Teva) Company Information
13.6.2 TAPI (Teva) Paclitaxel Product Portfolios and Specifications
13.6.3 TAPI (Teva) Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.6.4 TAPI (Teva) Main Business Overview
13.6.5 TAPI (Teva) Latest Developments
13.7 Fresenius-kabi
13.7.1 Fresenius-kabi Company Information
13.7.2 Fresenius-kabi Paclitaxel Product Portfolios and Specifications
13.7.3 Fresenius-kabi Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.7.4 Fresenius-kabi Main Business Overview
13.7.5 Fresenius-kabi Latest Developments
13.8 Huiang biopharma
13.8.1 Huiang biopharma Company Information
13.8.2 Huiang biopharma Paclitaxel Product Portfolios and Specifications
13.8.3 Huiang biopharma Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.8.4 Huiang biopharma Main Business Overview
13.8.5 Huiang biopharma Latest Developments
13.9 Southpharma
13.9.1 Southpharma Company Information
13.9.2 Southpharma Paclitaxel Product Portfolios and Specifications
13.9.3 Southpharma Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.9.4 Southpharma Main Business Overview
13.9.5 Southpharma Latest Developments
13.10 Yunnan Hande
13.10.1 Yunnan Hande Company Information
13.10.2 Yunnan Hande Paclitaxel Product Portfolios and Specifications
13.10.3 Yunnan Hande Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.10.4 Yunnan Hande Main Business Overview
13.10.5 Yunnan Hande Latest Developments
13.11 Hainan Yew Pharm
13.11.1 Hainan Yew Pharm Company Information
13.11.2 Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
13.11.3 Hainan Yew Pharm Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.11.4 Hainan Yew Pharm Main Business Overview
13.11.5 Hainan Yew Pharm Latest Developments
13.12 Jiangsu Yew Biotechnology
13.12.1 Jiangsu Yew Biotechnology Company Information
13.12.2 Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
13.12.3 Jiangsu Yew Biotechnology Paclitaxel Sales, Revenue, Price and Gross Margin (2018-2023)
13.12.4 Jiangsu Yew Biotechnology Main Business Overview
13.12.5 Jiangsu Yew Biotechnology Latest Developments
14 Research Findings and Conclusion

List of Tables
Table 1. Paclitaxel Annual Sales CAGR by Geographic Region (2018, 2022 & 2029) & ($ millions)
Table 2. Paclitaxel Annual Sales CAGR by Country/Region (2018, 2022 & 2029) & ($ millions)
Table 3. Major Players of Natural Paclitaxel API
Table 4. Major Players of Semi-synthetic Paclitaxel API
Table 5. Global Paclitaxel Sales by Type (2018-2023) & (Kg)
Table 6. Global Paclitaxel Sales Market Share by Type (2018-2023)
Table 7. Global Paclitaxel Revenue by Type (2018-2023) & ($ million)
Table 8. Global Paclitaxel Revenue Market Share by Type (2018-2023)
Table 9. Global Paclitaxel Sale Price by Type (2018-2023) & (USD/Kg)
Table 10. Global Paclitaxel Sales by Application (2018-2023) & (Kg)
Table 11. Global Paclitaxel Sales Market Share by Application (2018-2023)
Table 12. Global Paclitaxel Revenue by Application (2018-2023)
Table 13. Global Paclitaxel Revenue Market Share by Application (2018-2023)
Table 14. Global Paclitaxel Sale Price by Application (2018-2023) & (USD/Kg)
Table 15. Global Paclitaxel Sales by Company (2018-2023) & (Kg)
Table 16. Global Paclitaxel Sales Market Share by Company (2018-2023)
Table 17. Global Paclitaxel Revenue by Company (2018-2023) ($ Millions)
Table 18. Global Paclitaxel Revenue Market Share by Company (2018-2023)
Table 19. Global Paclitaxel Sale Price by Company (2018-2023) & (USD/Kg)
Table 20. Key Manufacturers Paclitaxel Producing Area Distribution and Sales Area
Table 21. Players Paclitaxel Products Offered
Table 22. Paclitaxel Concentration Ratio (CR3, CR5 and CR10) & (2018-2023)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Paclitaxel Sales by Geographic Region (2018-2023) & (Kg)
Table 26. Global Paclitaxel Sales Market Share Geographic Region (2018-2023)
Table 27. Global Paclitaxel Revenue by Geographic Region (2018-2023) & ($ millions)
Table 28. Global Paclitaxel Revenue Market Share by Geographic Region (2018-2023)
Table 29. Global Paclitaxel Sales by Country/Region (2018-2023) & (Kg)
Table 30. Global Paclitaxel Sales Market Share by Country/Region (2018-2023)
Table 31. Global Paclitaxel Revenue by Country/Region (2018-2023) & ($ millions)
Table 32. Global Paclitaxel Revenue Market Share by Country/Region (2018-2023)
Table 33. Americas Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 34. Americas Paclitaxel Sales Market Share by Country (2018-2023)
Table 35. Americas Paclitaxel Revenue by Country (2018-2023) & ($ Millions)
Table 36. Americas Paclitaxel Revenue Market Share by Country (2018-2023)
Table 37. Americas Paclitaxel Sales by Type (2018-2023) & (Kg)
Table 38. Americas Paclitaxel Sales by Application (2018-2023) & (Kg)
Table 39. APAC Paclitaxel Sales by Region (2018-2023) & (Kg)
Table 40. APAC Paclitaxel Sales Market Share by Region (2018-2023)
Table 41. APAC Paclitaxel Revenue by Region (2018-2023) & ($ Millions)
Table 42. APAC Paclitaxel Revenue Market Share by Region (2018-2023)
Table 43. APAC Paclitaxel Sales by Type (2018-2023) & (Kg)
Table 44. APAC Paclitaxel Sales by Application (2018-2023) & (Kg)
Table 45. Europe Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 46. Europe Paclitaxel Sales Market Share by Country (2018-2023)
Table 47. Europe Paclitaxel Revenue by Country (2018-2023) & ($ Millions)
Table 48. Europe Paclitaxel Revenue Market Share by Country (2018-2023)
Table 49. Europe Paclitaxel Sales by Type (2018-2023) & (Kg)
Table 50. Europe Paclitaxel Sales by Application (2018-2023) & (Kg)
Table 51. Middle East & Africa Paclitaxel Sales by Country (2018-2023) & (Kg)
Table 52. Middle East & Africa Paclitaxel Sales Market Share by Country (2018-2023)
Table 53. Middle East & Africa Paclitaxel Revenue by Country (2018-2023) & ($ Millions)
Table 54. Middle East & Africa Paclitaxel Revenue Market Share by Country (2018-2023)
Table 55. Middle East & Africa Paclitaxel Sales by Type (2018-2023) & (Kg)
Table 56. Middle East & Africa Paclitaxel Sales by Application (2018-2023) & (Kg)
Table 57. Key Market Drivers & Growth Opportunities of Paclitaxel
Table 58. Key Market Challenges & Risks of Paclitaxel
Table 59. Key Industry Trends of Paclitaxel
Table 60. Paclitaxel Raw Material
Table 61. Key Suppliers of Raw Materials
Table 62. Paclitaxel Distributors List
Table 63. Paclitaxel Customer List
Table 64. Global Paclitaxel Sales Forecast by Region (2024-2029) & (Kg)
Table 65. Global Paclitaxel Revenue Forecast by Region (2024-2029) & ($ millions)
Table 66. Americas Paclitaxel Sales Forecast by Country (2024-2029) & (Kg)
Table 67. Americas Paclitaxel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 68. APAC Paclitaxel Sales Forecast by Region (2024-2029) & (Kg)
Table 69. APAC Paclitaxel Revenue Forecast by Region (2024-2029) & ($ millions)
Table 70. Europe Paclitaxel Sales Forecast by Country (2024-2029) & (Kg)
Table 71. Europe Paclitaxel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 72. Middle East & Africa Paclitaxel Sales Forecast by Country (2024-2029) & (Kg)
Table 73. Middle East & Africa Paclitaxel Revenue Forecast by Country (2024-2029) & ($ millions)
Table 74. Global Paclitaxel Sales Forecast by Type (2024-2029) & (Kg)
Table 75. Global Paclitaxel Revenue Forecast by Type (2024-2029) & ($ Millions)
Table 76. Global Paclitaxel Sales Forecast by Application (2024-2029) & (Kg)
Table 77. Global Paclitaxel Revenue Forecast by Application (2024-2029) & ($ Millions)
Table 78. Phyton Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 79. Phyton Paclitaxel Product Portfolios and Specifications
Table 80. Phyton Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 81. Phyton Main Business
Table 82. Phyton Latest Developments
Table 83. ScinoPharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 84. ScinoPharm Paclitaxel Product Portfolios and Specifications
Table 85. ScinoPharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 86. ScinoPharm Main Business
Table 87. ScinoPharm Latest Developments
Table 88. Novasep Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 89. Novasep Paclitaxel Product Portfolios and Specifications
Table 90. Novasep Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 91. Novasep Main Business
Table 92. Novasep Latest Developments
Table 93. Samyang Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 94. Samyang Paclitaxel Product Portfolios and Specifications
Table 95. Samyang Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 96. Samyang Main Business
Table 97. Samyang Latest Developments
Table 98. Polymed Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 99. Polymed Paclitaxel Product Portfolios and Specifications
Table 100. Polymed Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 101. Polymed Main Business
Table 102. Polymed Latest Developments
Table 103. TAPI (Teva) Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 104. TAPI (Teva) Paclitaxel Product Portfolios and Specifications
Table 105. TAPI (Teva) Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 106. TAPI (Teva) Main Business
Table 107. TAPI (Teva) Latest Developments
Table 108. Fresenius-kabi Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 109. Fresenius-kabi Paclitaxel Product Portfolios and Specifications
Table 110. Fresenius-kabi Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 111. Fresenius-kabi Main Business
Table 112. Fresenius-kabi Latest Developments
Table 113. Huiang biopharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 114. Huiang biopharma Paclitaxel Product Portfolios and Specifications
Table 115. Huiang biopharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 116. Huiang biopharma Main Business
Table 117. Huiang biopharma Latest Developments
Table 118. Southpharma Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 119. Southpharma Paclitaxel Product Portfolios and Specifications
Table 120. Southpharma Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 121. Southpharma Main Business
Table 122. Southpharma Latest Developments
Table 123. Yunnan Hande Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 124. Yunnan Hande Paclitaxel Product Portfolios and Specifications
Table 125. Yunnan Hande Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 126. Yunnan Hande Main Business
Table 127. Yunnan Hande Latest Developments
Table 128. Hainan Yew Pharm Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 129. Hainan Yew Pharm Paclitaxel Product Portfolios and Specifications
Table 130. Hainan Yew Pharm Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 131. Hainan Yew Pharm Main Business
Table 132. Hainan Yew Pharm Latest Developments
Table 133. Jiangsu Yew Biotechnology Basic Information, Paclitaxel Manufacturing Base, Sales Area and Its Competitors
Table 134. Jiangsu Yew Biotechnology Paclitaxel Product Portfolios and Specifications
Table 135. Jiangsu Yew Biotechnology Paclitaxel Sales (Kg), Revenue ($ Million), Price (USD/Kg) and Gross Margin (2018-2023)
Table 136. Jiangsu Yew Biotechnology Main Business
Table 137. Jiangsu Yew Biotechnology Latest Developments
List of Figures
Figure 1. Picture of Paclitaxel
Figure 2. Paclitaxel Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Paclitaxel Sales Growth Rate 2018-2029 (Kg)
Figure 7. Global Paclitaxel Revenue Growth Rate 2018-2029 ($ Millions)
Figure 8. Paclitaxel Sales by Region (2018, 2022 & 2029) & ($ Millions)
Figure 9. Product Picture of Natural Paclitaxel API
Figure 10. Product Picture of Semi-synthetic Paclitaxel API
Figure 11. Global Paclitaxel Sales Market Share by Type in 2022
Figure 12. Global Paclitaxel Revenue Market Share by Type (2018-2023)
Figure 13. Paclitaxel Consumed in Ovarian Cancer
Figure 14. Global Paclitaxel Market: Ovarian Cancer (2018-2023) & (Kg)
Figure 15. Paclitaxel Consumed in Cervical Cancer
Figure 16. Global Paclitaxel Market: Cervical Cancer (2018-2023) & (Kg)
Figure 17. Paclitaxel Consumed in Breast Cancer
Figure 18. Global Paclitaxel Market: Breast Cancer (2018-2023) & (Kg)
Figure 19. Paclitaxel Consumed in Others
Figure 20. Global Paclitaxel Market: Others (2018-2023) & (Kg)
Figure 21. Global Paclitaxel Sales Market Share by Application (2022)
Figure 22. Global Paclitaxel Revenue Market Share by Application in 2022
Figure 23. Paclitaxel Sales Market by Company in 2022 (Kg)
Figure 24. Global Paclitaxel Sales Market Share by Company in 2022
Figure 25. Paclitaxel Revenue Market by Company in 2022 ($ Million)
Figure 26. Global Paclitaxel Revenue Market Share by Company in 2022
Figure 27. Global Paclitaxel Sales Market Share by Geographic Region (2018-2023)
Figure 28. Global Paclitaxel Revenue Market Share by Geographic Region in 2022
Figure 29. Americas Paclitaxel Sales 2018-2023 (Kg)
Figure 30. Americas Paclitaxel Revenue 2018-2023 ($ Millions)
Figure 31. APAC Paclitaxel Sales 2018-2023 (Kg)
Figure 32. APAC Paclitaxel Revenue 2018-2023 ($ Millions)
Figure 33. Europe Paclitaxel Sales 2018-2023 (Kg)
Figure 34. Europe Paclitaxel Revenue 2018-2023 ($ Millions)
Figure 35. Middle East & Africa Paclitaxel Sales 2018-2023 (Kg)
Figure 36. Middle East & Africa Paclitaxel Revenue 2018-2023 ($ Millions)
Figure 37. Americas Paclitaxel Sales Market Share by Country in 2022
Figure 38. Americas Paclitaxel Revenue Market Share by Country in 2022
Figure 39. Americas Paclitaxel Sales Market Share by Type (2018-2023)
Figure 40. Americas Paclitaxel Sales Market Share by Application (2018-2023)
Figure 41. United States Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 42. Canada Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 43. Mexico Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 44. Brazil Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 45. APAC Paclitaxel Sales Market Share by Region in 2022
Figure 46. APAC Paclitaxel Revenue Market Share by Regions in 2022
Figure 47. APAC Paclitaxel Sales Market Share by Type (2018-2023)
Figure 48. APAC Paclitaxel Sales Market Share by Application (2018-2023)
Figure 49. China Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 50. Japan Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 51. South Korea Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 52. Southeast Asia Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 53. India Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 54. Australia Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 55. China Taiwan Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 56. Europe Paclitaxel Sales Market Share by Country in 2022
Figure 57. Europe Paclitaxel Revenue Market Share by Country in 2022
Figure 58. Europe Paclitaxel Sales Market Share by Type (2018-2023)
Figure 59. Europe Paclitaxel Sales Market Share by Application (2018-2023)
Figure 60. Germany Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 61. France Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 62. UK Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 63. Italy Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 64. Russia Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 65. Middle East & Africa Paclitaxel Sales Market Share by Country in 2022
Figure 66. Middle East & Africa Paclitaxel Revenue Market Share by Country in 2022
Figure 67. Middle East & Africa Paclitaxel Sales Market Share by Type (2018-2023)
Figure 68. Middle East & Africa Paclitaxel Sales Market Share by Application (2018-2023)
Figure 69. Egypt Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 70. South Africa Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 71. Israel Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 72. Turkey Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 73. GCC Country Paclitaxel Revenue Growth 2018-2023 ($ Millions)
Figure 74. Manufacturing Cost Structure Analysis of Paclitaxel in 2022
Figure 75. Manufacturing Process Analysis of Paclitaxel
Figure 76. Industry Chain Structure of Paclitaxel
Figure 77. Channels of Distribution
Figure 78. Global Paclitaxel Sales Market Forecast by Region (2024-2029)
Figure 79. Global Paclitaxel Revenue Market Share Forecast by Region (2024-2029)
Figure 80. Global Paclitaxel Sales Market Share Forecast by Type (2024-2029)
Figure 81. Global Paclitaxel Revenue Market Share Forecast by Type (2024-2029)
Figure 82. Global Paclitaxel Sales Market Share Forecast by Application (2024-2029)
Figure 83. Global Paclitaxel Revenue Market Share Forecast by Application (2024-2029)
  • Global 5-Fluorouracil Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 76
    The global 5-Fluorouracil market was valued at US$ 283 million in 2023 and is anticipated to reach US$ 487.9 million by 2030, witnessing a CAGR of 4.3% during The forecast period 2024-2030. North American market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for 5-Fluorouracil is estimated to increase from $ million in 2023 to reach $ million by ......
  • Global Carboplatin Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79
    The global Carboplatin market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Carboplatin is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % d......
  • Global Neutropenia Drugs Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 96
    The global Neutropenia Drugs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated to increa......
  • Global Small Molecule Cancer Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Small Molecule Cancer Drug market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated ......
  • Global Capecitabine Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 80
    Capecitabine is an orally-administered chemotherapeutic agent used in The treatment of metastatic breast and colorectal cancers. Capecitabine is a prodrug, which is enzymatically converted to fluorouracil (antimetabolite) in The tumor, where it inhibits DNA synthesis and slows growth of tumor tissue. Common side effects include abdominal pain, vomiting, diarrhea, weakness, and rashes. Other severe side effects include blood clotting problems, allergic reactions, heart problems, and low blo......
  • Global Oxaliplatin Market Research Report 2024
    Published: 08-Jan-2024        Price: US 2900 Onwards        Pages: 104
    Oxaliplatin is a platinum-based anticancer drug with colorless or nearly colorless transparent liquid. It is often used for metastatic colorectal cancer treatment or adjuvant therapy The third stage colon cancer after resecting primary tumor completely. In this report, only The finished drug is covered, exclude API. The global Oxaliplatin market was valued at US$ 897.5 million in 2023 and is anticipated to reach US$ 1641.5 million by 2030, witnessing a CAGR of 8.9% duri......
  • Global Cancer Treatment Drugs Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 158
    According to our LPI (LP Information) latest study, the global Cancer Treatment Drugs market size was valued at US$ 174990 million in 2023. With growing demand in downstream market, the Cancer Treatment Drugs is forecast to a readjusted size of US$ 322540 million by 2030 with a CAGR of 9.1% during review period. The research report highlights the growth potential of the global Cancer Treatment Drugs market. Cancer Treatment Drugs are expected to show stable growth in the future market. H......
  • Global Capecitabine Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 93
    According to our LPI (LP Information) latest study, the global Capecitabine market size was valued at US$ 1003.9 million in 2023. With growing demand in downstream market, the Capecitabine is forecast to a readjusted size of US$ 975.1 million by 2030 with a CAGR of -0.4% during review period. The research report highlights the growth potential of the global Capecitabine market. Capecitabine are expected to show stable growth in the future market. However, product differentiation, reducin......
  • Global Methotrexate Market Growth 2024-2030
    Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 95
    According to our LPI (LP Information) latest study, the global Methotrexate market size was valued at US$ 506 million in 2023. With growing demand in downstream market, the Methotrexate is forecast to a readjusted size of US$ 613.9 million by 2030 with a CAGR of 2.8% during review period. The research report highlights the growth potential of the global Methotrexate market. Methotrexate are expected to show stable growth in the future market. However, product differentiation, reducing co......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs